The Scientist Logo_white

Advances in Solid Tumor Immunotherapies

By screening for novel tumor targets, researchers build better CAR T cell therapies.




Researchers face unique challenges when developing therapies for solid tumors, including cell heterogeneity, drug resistance, and a complex tumor microenvironment. To design ideal CAR T cells for treating solid tumors, scientists screen for novel targets and optimize their workflows with sophisticated instruments.

Download this ebook from Sartorius to learn about developing new CAR T therapies for solid tumors.